DS
LSPRU

David Shaw’s Larkspur Health Acquisition Corp. Unit LSPRU Stock Holding History

David Shaw’s Portfolio LSPRU Stock Details LSPRU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-233,334
Closed -$2.34M – 5979
2022
Q1 		$2.34M Sell
233,334
-116,666
-33% -$1.16M ﹤0.01% 3157
2021
Q4 		$3.51M Buy
+350,000
New +$3.5M ﹤0.01% 2780

Other funds holding LSPRU

YCM
Yakira Capital Management Westport, Connecticut $351M AUM 21.82% 1-Year Est. Return
RCM
Rivernorth Capital Management West Palm Beach, Florida $2.1B AUM 2.15% 1-Year Est. Return
CSS
Cubist Systematic Strategies Stamford, Connecticut $21B AUM 21.48% 1-Year Est. Return
RL
RPO LLC Stamford, Connecticut $30.4M AUM 3.41% 1-Year Est. Return
BI
Bulldog Investors Saddle Brook, New Jersey $455M AUM 2.3% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
MP
Mangrove Partners Greenwich, Connecticut $1.52B AUM 36.54% 1-Year Est. Return
MIG
Mariner Investment Group Harrison, New York $463M AUM 13.33% 1-Year Est. Return

David Shaw's LSPRU Position: Q2 2022 in Review

David Shaw sold out of Larkspur Health Acquisition Corp. Unit (LSPRU) in Q2 2022, closing a stake of 233,334 shares — an estimated $2.34M sold.

David Shaw first reported a position in LSPRU in Q4 2021 and held it in 2 quarters. The position peaked at $3.51M in Q4 2021. 8 funds tracked by Wall St. Rank hold LSPRU as of Q2 2022.

  • David Shaw reported no remaining Larkspur Health Acquisition Corp. Unit position as of Q2 2022 after selling out during the quarter.
  • David Shaw sold 233,334 Larkspur Health Acquisition Corp. Unit shares in Q2 2022, an estimated $2.34M.
  • David Shaw first reported a position in Larkspur Health Acquisition Corp. Unit in Q4 2021 and held it in 2 quarters.
  • David Shaw's Larkspur Health Acquisition Corp. Unit position peaked at $3.51M in Q4 2021.
  • 8 funds tracked by Wall St. Rank held Larkspur Health Acquisition Corp. Unit as of Q2 2022.

Based on D.E. Shaw & Co's 13F filing for Q2 2022, filed 15 Aug 2022.